Tessera
Folgen

🇨🇷 Rolando Ulloa-Gutierrez

@rolandoug.bsky.social

Investigador Hospital Nacional de Niños de Costa Rica, Miembro Academia Nacional de Medicina 🇨🇷. Kawasaki, vaccines, RSV, global health, networks. #IDsky #pedsid PubMed publications👇 https://pubmed.ncbi.nlm.nih.gov/?term=ulloa-gutierrez+r&sort=date&size=200

129 Posts168 Follower185 Folgt
🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · 2mo ago

Nuestra publicación sobre la importancia de estudios y publicaciones internacionales en #EnfermedaddeKawasaki. Gracias a todos nuestros investigadores de la red #REKAMLATINA por su trabajo en #KawasakiDisease en Latinoamérica. En Journal del @americanheart.bsky.social doi.org/10.1161/jaha... #idsky

Importance of Fostering International Collaboration for Optimal Outcomes of Kawasaki Disease Worldwide: A Science Advisory From the American Heart Association | Journal of the American Heart Associati...

doi.org

🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · 2mo ago

1. El 1er caso reportado de #Leishmaniasisvisceral en niños de #CostaRica 🇨🇷fue publicado hace 27 años en @cidjournal.bsky.social (1999) en un bebé de 15 meses. Desde entonces es probable que hayamos tenido más casos, al igual que en otros países de CentroAmérica. #idsky doi.org/10.1086/598653

Visceral Leishmaniasis in Costa Rica: First Case Report

Abstract. We describe a 15-month-old eutrophic immunocompetent male who presented with fever, hepatosplenomegaly, pancytopenia, and hypergammaglobulinemia.

doi.org

🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · 3mo ago

Hace 1 año en la reunión de la Global Pertussis Initiative (GPI) analizamos la situación de #pertussis #tosferina en Europa, donde el # de casos ↗️ dramáticamente en 2023 y 2024, así como en Latinoamérica y otras regiones. #whoopingcough #globalpertussisinitiative #idsky doi.org/10.1007/s401...

The Ongoing Challenge of Pertussis in Eastern and Northern Europe: Recommendations from the Global Pertussis Initiative - Infectious Diseases and Therapy

Pertussis (whooping cough), a vaccine-preventable disease that affects people of any age, has resurged globally after the COVID-19 pandemic. Key reasons for recent pertussis outbreaks include suboptimal pertussis vaccination coverage (particularly for vaccination during pregnancy) and growing vaccination hesitancy. During the 2023–2024 pertussis outbreaks in Europe, adolescents aged 10–14 years and 15–19 years had the first and third highest incidence rates, respectively. To reduce pertussis burden, it is essential to strengthen vaccination programs in the indicated target groups. This requires increased awareness among healthcare professionals about the local epidemiology of pertussis and its clinical presentation, alongside reinforcement of the benefits of vaccination for disease prevention. In parallel, robust surveillance systems and strong public health capacity for early disease detection and response are crucial to effectively manage outbreaks and build resilience against future outbreaks. Infants remain at high risk for pertussis, with complications, hospitalisation, and death being more common than in other age groups. Immunisation programmes combining vaccination during pregnancy, to protect newborn infants until their primary immunisation series has induced immunity, and infant immunisation are key to reducing morbidity and mortality. Strategies to improve pertussis vaccination uptake among adolescents and adults, especially those with high-risk medical conditions, are also essential. Strengthening global collaborations to invest in and build surveillance systems capable of identifying and responding to future outbreaks, to align national policies, to scale up immunisation during pregnancy, and to adopt a life-long immunisation approach are needed to better control endemic pertussis and manage future outbreaks.

doi.org

🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · 4mo ago

Así se previene el Virus Respiratorio Sincitial #VRS #RSV en el adulto mayor en 🏴󠁧󠁢󠁥󠁮󠁧󠁿. #stoprsv

Oxford Vaccine Group@ovg.ox.ac.uk · 4mo ago

📣 Respiratory syncytial virus (RSV) vaccine eligibility expanded in England 🗓️ Commencing the 1st of April 2026, the NHS has expanded eligibility for the RSV vaccine to now include: ➡️ Adults aged 80 and over (with no upper age limit) ➡️ Residents in care homes for older adults

ACOG@acog.org · 11mo ago

ACOG reaffirms that acetaminophen is safe for managing pain and fever during pregnancy. No reputable studies support suggestions like those in HHS’s recent announcement linking acetaminophen use in pregnancy to autism; in fact, high-quality studies show no such risk. https://bit.ly/47Wxc59

Bild
🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · 11mo ago

En Latinoamérica tenemos brotes recientes importantes de #pertussis #tosferina en varios países, ⬆️ de fallecidos y ⬇️ coberturas de vacunación en varias regiones. Desconocemos la prevalencia de cepas resistentes de Bp a macrólidos. Por tanto, ⬆️ vacunación es vital: www.paho.org/en/news/26-8...

PAHO calls for strengthened vaccination and surveillance amid the spread of antibiotic-resistant pertussis in the Americas

Washington, D.C., August 26, 2025 (PAHO) – In light of the resurgence of pertussis across several countries in the region and the emergence and spread of antibiotic-resistant strains, the Pan American...

paho.org

Gavi@gavi.org · 11mo ago

Vaccines save lives, but misinformation spreads faster than viruses. In some communities, it only takes one rumour to keep parents away from health centres. Muslim faith leaders in Burundi are stepping in to stop that cycle. Here’s how. 🧵

Bild
🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · last yr.

#Clesrovimab recibe aprobación por la FDA para la prevención del Virus Respiratorio Sincitial #VRS en infantes. Muy positiva noticia dada a conocer hoy y aumentan las opciones de prevención. #rsv #stoprsv www.merck.com/news/u-s-fda...

U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Born During or Entering Their First RSV Season - ...

ENFLONSIA is a preventive monoclonal antibody designed to protect infants against a spectrum of RSV disease severity, including worsening disease requiring hospitalization ENFLONSIA is the first and o...

merck.com

🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · last yr.

Our publication about #pertussis in LatAm in @ofidjournal.bsky.social highlights many needs 🔜: * Improved surveillance, more engagement by Ob/Gyn's & midwifes, ⬆️ rates of Tdap vaccination among pregnant women. #tosferina #whoopingcough #globalpertussisinitiative #idsky doi.org/10.1093/ofid...

Country-Specific Data and Priorities for Pertussis in Latin America: Recent Findings From the Global Pertussis Initiative

This article provides a comprehensive analysis of pertussis epidemiology, surveillance strategies, and vaccination policies in Latin America. It highlights

doi.org

🇨🇷 Rolando Ulloa-Gutierrez@rolandoug.bsky.social · last yr.

Primer caso de #sarampión importado del 2025 en Costa Rica en una joven extranjera de 18 años, quien lamentablemente no estaba vacunada. Esto demuestra, una vez más, el por qué se insiste en la vacunación. #measles #costarica www.ministeriodesalud.go.cr/index.php/pr...

Ministerio de Salud confirma caso importado de sarampión en Guanacaste

El Ministerio de Salud de Costa Rica en su rol de Rector de Salud coloca a disposición de la población nacional e internacional la información referente a los t

ministeriodesalud.go.cr